$132 Million is the total value of Privium Fund Management (UK) Ltd's 54 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TDW | TIDEWATER INC NEW | $9,889,029 | +69.8% | 268,359 | 0.0% | 7.51% | +1.1% | |
| GLD | SPDR GOLD TR | $508,920 | +9.7% | 3,000 | 0.0% | 0.39% | -34.8% | |
| SNAP INCput | $388,570 | +12.3% | 910 | 0.0% | 0.30% | -33.1% | ||
| BOLT | BOLT BIOTHERAPEUTICS INC | $151,471 | -11.9% | 116,516 | 0.0% | 0.12% | -47.5% | |
| MREO | MEREO BIOPHARMA GROUP PLCspon ads | $132,900 | -13.1% | 177,200 | 0.0% | 0.10% | -48.2% | |
| NLTX | NEOLEUKIN THERAPEUTICS INC | $59,655 | -20.5% | 117,200 | 0.0% | 0.04% | -53.1% | |
| TSCAN THERAPEUTICS INC | $24,529 | -48.9% | 15,825 | 0.0% | 0.02% | -68.9% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-09
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ALASKA AIR GROUP INC | 11 | Q3 2023 | 2.6% |
| CONTROLADORA VUELA COMP DE A | 11 | Q3 2023 | 1.7% |
| ALPHABET INC | 10 | Q3 2023 | 10.1% |
| COPA HOLDINGS SA | 9 | Q3 2023 | 1.8% |
| DELTA AIR LINES INC DEL | 8 | Q3 2023 | 2.7% |
| SPDR GOLD TR | 8 | Q4 2022 | 1.6% |
| ACELRX PHARMACEUTICALS INC | 8 | Q3 2022 | 0.0% |
| ISHARES INC | 7 | Q3 2023 | 5.4% |
| TECK RESOURCES LTD | 7 | Q3 2022 | 1.9% |
| ISHARES TR | 7 | Q3 2023 | 2.1% |
View Privium Fund Management (UK) Ltd's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-29 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-07-26 |
| 13F-HR | 2023-05-03 |
| 13F-HR | 2023-02-09 |
| 13F-HR | 2022-11-01 |
| 13F-HR | 2022-07-28 |
| 13F-HR | 2022-05-10 |
| 13F-HR/A | 2022-03-25 |
View Privium Fund Management (UK) Ltd's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.